Skip to Content

CFB 135 (Fenofibric Acid Delayed-Release 135 mg)

Pill with imprint CFB 135 is Blue & Yellow, Capsule-shape and has been identified as Fenofibric Acid Delayed-Release 135 mg. It is supplied by Aurobindo Pharma Limited.

Fenofibric acid is used in the treatment of hypertriglyceridemia; high cholesterol and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CFB 135

Fenofibric acid delayed-release 135 mg CFB 135

Fenofibric Acid Delayed-Release

Imprint
CFB 135
Strength
135 mg
Color
Blue & Yellow
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Aurobindo Pharma Limited
National Drug Code (NDC)
59651-0217

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.